Safety and effectiveness of BIAsp 30 treatment: Data from the Moroccan cohort of the A1chieve study

International Journal of Medicine and Medical Sciences

Farida Ajdi¹  Naoual El Ansari²  Ahmed Farouqi³  Abdelmjid Chraibi⁴  Jamal Belkhadir⁵  Fatima Marouan⁶  Chunduo Shen⁷  Anil Shinde⁸ 

[1] Diabetes, Endocrinology and Nutrition Department, Centre Hospitalier Universitaire Hassan II, Fes, Morocco.;Diabetes, Endocrinology and Nutrition Department, Hospital IbnTofail, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco.;Diabetes, Endocrinology and Nutrition Department, Ibn Rochd University Hospital, Casablanca, Morocco.;Diabetes, Endocrinology and Nutrition Department, Ibn Sina Hospital, Mohammed V Souissi University, Rabat, Morocco.;Endocrinology and Nutrition, 28, avenue de France, appt.8 3掳茅t.10090, Rabat, Morocco.;Endocrinology and Nutrition, Rue Al Hassan Azzaafrani Villa Delice, Casablanca, Morocco.;Novo Nordisk International Operations A/S, Z眉rich, Switzerland;Novo Nordisk Pharma Gulf, FZ6LLC Dubai Healthcare City.

关键词: Type 2 diabetes;    BIAsp 30;    Morocco;    non-interventional study;    glycaemic control.;   

学科分类：医学（综合）

来源: Academic Journals

【 授权许可】

Others